Expressing Non-small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-08-18
Clinical Trial Update: A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers [Phase 1, Phase 2]
Phase 1/2 safety and activity study of SBT6050 in combination with other HER2-directed therapies for HER2-positive cancers; the trial status…